Novocure Reports Third Quarter 2019 Financial Results and Provides Company Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
Novocure (NVCR) Tops Q3 EPS by 7c, Revenues Beat
October 31, 2019 6:40 AM EDTNovocure (NASDAQ: NVCR) reported Q3 EPS of $0.02, $0.07 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $92.1 million versus the consensus estimate of $87.08 million.
Quarterly net revenues of $92.1 million, representing 42% growth versus the third quarter 2018First quarter ever of positive net income with $0.02 in earnings per shareContinued clinical... More


